Arbidol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
K. Liu, Z. Dong, N. Yang, X. Lu, Y. Jiang, L. Zhao, D. Wang, Y. Wei, Y. Yu, M. O. Kim, K. V. Laster, X. Li, B. Yuan
This study shows Arbidol inhibits esophageal squamous cell carcinoma growth by targeting the ATR kinase and disrupting the DNA replication pathway.
bioRxiv · Feb 15, 2022 · PreprintCancer Biology